Proton pump inhibitors
Keywords: proton pump inhibitors, gastro-oesophageal reflux disease, GORD, peptic ulcers
AbstractProton pump inhibitors (PPI’s) are a class of drugs that profoundly suppress gastric acid secretion and have thus become the treatment of choice for gastro-oesophageal reflux disease (GORD) and peptic ulcer disease (PUD). PPI’s are considered safe and effective. It is essential that clinicians understand the appropriate use of PPI’s given the significant economic burden of inappropriate prescribing and safety concerns. Long term safety concerns and possible drug interactions have led to a more conservative approach to PPI use. Some of these concerns may have been overstated but it does serve to highlight the need for ongoing vigilance as even a small increased risk for an adverse event may translate to large numbers considering the widespread use of PPI’s. This review will focus on the use of oral PPI’s in the ambulatory setting and recent concerns regarding adverse effects of PPI’s.
By submitting manuscripts to SAPJ, authors of original articles are assigning copyright to Medpharm Publications (Pty) Ltd. Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in SAPJ for educational and research purposes without obtaining permission.